Opus Genetics, Inc. Other Accrued Liabilities, Current
Opus Genetics, Inc. (IRD) had Other Accrued Liabilities, Current of $21.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Other Accrued Liabilities, Current $21.00K.
- 2026-03-31: Other Accrued Liabilities, Current $15.00K.
- 2025-12-31: Other Accrued Liabilities, Current $15.00K.
- 2025-09-30: Other Accrued Liabilities, Current $268.00K.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $21.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $15.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $15.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $268.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $265.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $380.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $606.00K 10-K · filed 2026-03-12 | $604.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $63.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $96.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $95.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $71.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $49.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $43.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $167.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $74.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $39.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $75.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $80.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $8.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $16.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $26.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $25.00K 10-K · filed 2022-03-24 | |
| 2019-12-31 | $9.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |